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Introduction: Excimer laser energy is often required to extract chronically indwelling pacemaker and deﬁbrillator
leads from the vasculature andmyocardium. This technique can be associatedwith vascular and right ventricular
(RV) injuries. We sought to develop a safer, more effective method by applying site-speciﬁc delivery of electro-
surgical energy (EE).
Methods:Utilizing a polyacrylamide gel model to simulate soft tissue density, active and passive ﬁxation deﬁbril-
lator and pacemaker leadswere implanted andmanually extractedwith andwithout EE delivered to the cathode.
The amount of force required for complete removal was measured using a force transducer. The procedure was
then repeated in an acute pig model to demonstrate proof of safety. Post mortem gross and histologic specimens
were collected from the implantation site.
Results: In the gelmodel, the force required for extraction, usingmanual traction in the active (83.7 g) and passive
(74.6 g) ﬁxation ICD leads, was reduced by 37.8% and 33.5%, respectively with EE (both p b 0.01). The force re-
quired for extraction, using manual traction in the active (85.2 g) and passive (71.9 g) ﬁxation pacemaker
leads, was reduced by 64.4% and 42.6%, respectively with EE (both p b 0.01). In an acute implantation pig
model using an active ﬁxation lead, delivery of EE to the cathode (n= 6) reduced the force required tomanually
extract the lead (140 g+/− 32.5 versus 82 g+/− 14.7, p= 0.03). Postmortem analysis of the RV displayed for-
mation of an epicardial hemorrhagic lesion thatwas also present aftermanual traction andEE. Therewas absence
of pericardial effusion, perforation, and ventricular arrhythmia.
Conclusions: Site-speciﬁc delivery of EE to areas of exposed metal along the lead decreased the force necessary
for lead extraction in an in vitro and in vivo model. Further studies are needed to evaluate its application in
clinical care.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
The number of implanted cardiac implantable electronic devices
(CIEDs) has steadily increased over the past decade. The emergence
of pacing and implantable cardioverter–deﬁbrillator (ICD) systems,
along with expanding indications of these devices (e.g., cardiac
resynchronization therapy and sudden cardiac death prevention), in-
creasing infection rates, and device recalls has created a greater need
for removing and upgrading indwelling transvenous leads [1]. Unfortu-
nately, lead removal is often complicated by the development of a ﬁ-
brous material around the leads over time. In fact, the longer theic devices; ICD, implantable
E, electrosurgical energy; SVC,
gie 568, Baltimore, MD 21287,
019.
d Ltd. This is an open access article undindwelling lead has been implanted, themore difﬁcult the process of ex-
traction. In-depth analyses of extracted leads have shown that ﬁbrous
adhesions do not occur uniformly over the length of the lead. In fact,
there appears to be a greater predilection for ﬁbrous tissue develop-
ment at the deﬁbrillator coils and the tip of the implanted lead [2–6].
Deﬁbrillator coil-associated adhesions have often required the applica-
tion of more advanced methodologies beyond simple traction such as
dilating sheaths, snares, and excimer laser sheaths. But when only the
tip of the lead remains ﬁbrosed to the myocardial wall, few options
are available for safe removal. The current standard of care is the appli-
cation of increasing degrees of manual traction. This can either result in
hemodynamically signiﬁcant right ventricular eversion or potentially
fatal vascular or myocardial avulsions. We sought to develop a poten-
tially safer method of freeing the lead tip from ﬁbrous adhesions
through site-speciﬁc energy delivery capable of disintegrating ﬁbrous
tissues at regions of the lead most prone to tissue formation. We hy-
pothesized that delivering electrosurgical energy to these sites woulder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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removal.Fig. 2. Force required to manually extract pacemaker and implantable-cardioverter leads
in an in vivo model with and without EE application.2. Methods
Utilizing a 4.0% polyacrylamide gel model to simulate ﬁbrous tissue
density, active and passive ﬁxation deﬁbrillator (Medtronic Sprint
Quattro 6947, Mounds View, MN) and pacemaker leads (St Jude Tendril
1888, Sylmar, CA) were implanted and manually extracted with and
without EE delivered to the cathode in a unipolar conﬁguration. The
amount of force required for complete removal was measured using a
force transducer for a total of eighty lead extraction removal procedures.
The procedure was then repeated in an acute pig model to demonstrate
proof of safety. The porcine internal jugular vein was located via ultra-
sound and vascular sheathswere inserted via amodiﬁed Seldinger tech-
nique. The transvenous pacemaker lead was then inserted through the
sheath into the right ventricle under ﬂuoroscopic guidance. A secure
site was found and in the case of an active ﬁxation lead, the helix was
deployed. A force transducer was attached to the proximal portion of
the lead. The lead was then extracted using manual traction and the
force required to extract the lead from the myocardiumwas measured.
The same procedurewas then repeatedwith EE. An alligator clipwas at-
tached to the portion of the lead pin that corresponded to the cathode of
the lead. Unipolar EE was delivered utilizing a standard electrosurgical
device (Covidien, Mansﬁeld, MA) programmed to a maximum output
with a 100% duty cycle. During EE delivery manual traction was applied
and the force required to extract the lead from themyocardiumwas re-
corded. In both groups a live ﬂuoroscopic imagewas taken and stored to
demonstrate the course of the lead during extraction. This process was
repeated with the deﬁbrillator lead. Both active and passive ﬁxation
mechanisms were used. Post mortem gross and histologic specimens
were then collected from the implantation site.Fig. 1. Force required to manually extract pacemaker and implantable cardioverter-leads
in an in vitro model with and without EE application.3. Results
In the gel model, the average force required for extraction, using
manual traction in the active (83.7 g) and passive (74.6 g) ﬁxation ICD
leads, was reduced by 37.8% and 33.5%, respectively with EE
(both p b 0.01). The force required for extraction, using manual
traction in the active (85.2 g) and passive (71.9 g) ﬁxationFig. 3. Post mortem right ventricular site of implantation with accompanying epicardial
hemorrhage. Manual traction only (top) and manual traction with EE application
(bottom). (Arrows indicate the site of implantation).
Fig. 4. Post mortem right ventricular site of implantation with accompanying endocardial
hemorrhage. Manual traction only (top) and manual traction with EE application (bot-
tom). (Arrows indicate the site of implantation).
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with EE (both p b 0.01). Fig. 1 illustrates the force required to man-
ually extract the leads from the gel with and without application of
EE.
In the pig model, acute implantation of an active ﬁxation lead
and delivery of EE to the cathode (n = 6) reduced the force required
to manually extract the lead (140 g +/− 32.5 versus 82 g +/− 14.7,
p = 0.03). Fig. 2 illustrates the force required to manually extract the
leads from the pig once acutely implanted with and without EE. Post
mortem analysis of the RV displayed formation of an epicardial hemor-
rhagic lesion that was also present after manual traction and simulta-
neous delivery of EE (Figs. 3–4). Additional post mortem observations
included the absence of pericardial effusion, right ventricular perfora-
tion and ventricular arrhythmia.4. Discussion
Transvenous lead extractions are often complicated by the develop-
ment of adherent ﬁbrous tissues surrounding the leads. Often this oc-
curs in a heterogeneous pattern predominantly involving deﬁbrillator
coils and the cathode pacing tip.While all current extractionmethodol-
ogies employ some degree of lead traction, innovations including
the use of lead locking stylets, stainless steel telescoping sheaths
and excimer laser sheaths have signiﬁcantly improved efﬁcacy and
safety [7].Despite this, limitations continue to exist. Byrd et al. demonstrated
that excimer laser assisted lead extraction is effective but carried major
complication risks among 301 patients when compared to non-laser
methods [9,10]. Once adhesions have been freed from the main body
of the lead, the roles of laser and radiofrequency energy-facilitated
sheaths are limited. In the case of an activeﬁxation helix, failure to retract
the activemechanism of the helix usually indicates ﬁbrous adhesion for-
mation at the lead–myocardial interface. Cano et al. demonstrated that in
thirty-one consecutive patients undergoing active-ﬁxation lead removal,
therewas a 22.5% failure rate ofﬁxationmechanisms failing to retract [8].
At this point the operator is left with applyingmanual traction to free the
distal dip of the lead from the myocardium. As the operator advances
closer to the lead–myocardial interface, the risk of laceration increases
with energy delivery. Other techniques utilizing novel catheters or ener-
gy sources have also been tried. Talreja et al. reported using radiofre-
quency energy delivered with a steerable ablation catheter to facilitate
lead removal. With a short series of RF ablations, the pacemaker lead
tip was successfully freed without complication [11].
In clinical situationswhen application of laser energy has successful-
ly freed a chronically indwelling lead from the vasculature but not the
tip, our ﬁndings suggest an alternative of just simple traction. By apply-
ing electrosurgical energy directly to the IS-1 pin of the lead tip, one is
able to selectively deliver pulverizing energy in a site-speciﬁc manner
thereby focusing the energy only to areas necessary and potentially
minimizing energy delivery to neighboring structures. These studies
demonstrate a novel technique to facilitate lead extraction and illustrate
proof of concept of thismethodology aswell as proof of safety in a swine
in vivo model. An additional advantage of this technique is that this can
be performed without introduction of additional catheters and without
obtaining additional vascular access for introduction of long sheaths to
facilitate catheter manipulation. This potentially carries with it a lower
risk of vascular and myocardial catheter related injury.
5. Conclusions
Site-speciﬁc delivery of EE to areas of exposedmetal along pacemak-
er and ICD leads decreased the force necessary for lead extraction in an
in vitro and in vivo model. More importantly there was no evidence of
cardiac complication during or after a successful extraction procedure.
Givenour results anddemonstrationof safetywithmaximumoutputofEE
delivery, further studies are needed to evaluate its application in clinical care.
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